Form 4 for KVYO Klaviyo, Inc.
Accepted 2025-05-16 00:00:00 ET · period of report 2025-05-14 · accession 0001835830-25-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-16 | 2025-05-16 | KVYO | Bialecki Andrew | CEO, Dir, 10% | S - Sale | $32.90 | -10.97M | 0 | -100% | -$360.88M |
| D | 2025-05-16 | 2025-05-14 | KVYO | Bialecki Andrew | CEO, Dir, 10% | C - Cnv Deriv | $0.00 | +10.97M | 10.97M | New | $0 |
| DM | 2025-05-16 | 2025-05-14 | KVYO | Bialecki Andrew | CEO, Dir, 10% | M - OptEx | $0.005 | 0 | 0 | New | $0 |
| D | 2025-05-16 | 2025-05-14 | KVYO | Bialecki Andrew | CEO, Dir, 10% | C - Cnv Deriv | $0.00 | -10.97M | 74.87M | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2025-05-16 | S | D | 10,969,078 | $32.90 | 0 | D | — | — | |
| 2 | Common | Series A Common Stock | 2025-05-14 | C | A | 10,969,078 | $0.00 | 10,969,078 | D | — | — | |
| 3 | Derivative | Series B Common Stock | 2025-05-14 | M | A | 21,429,184 | $0.01 | 85,842,354 | D | — · — to — | 21,429,184 Series A Common Stock | (F4) Reflects 4,054,170 shares of Series B Common Stock previously transferred from the Andrew P. Bialecki Grantor Retained Annuity Trust I of 2023 to the Reporting Person. (F3) Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 4 | Derivative | Series B Common Stock | 2025-05-14 | C | D | 10,969,078 | $0.00 | 74,873,276 | D | — · — to — | 10,969,078 Series A Common Stock | (F3) Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-05-14 | M | D | 15,829,184 | $0.00 | 0 | D | $0.01 · — to 2025-08-31 | 15,829,184 Series B Common Stock | (F2) The shares underlying this option were fully vested and exercisable by the Reporting Person as of the date exercised. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-05-14 | M | D | 5,600,000 | $0.00 | 0 | D | $0.01 · — to 2025-09-28 | 5,600,000 Series B Common Stock | (F2) The shares underlying this option were fully vested and exercisable by the Reporting Person as of the date exercised. |